Cytisine structure
|
Common Name | Cytisine | ||
---|---|---|---|---|
CAS Number | 485-35-8 | Molecular Weight | 190.242 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 413.0±34.0 °C at 760 mmHg | |
Molecular Formula | C11H14N2O | Melting Point | 154-156ºC | |
MSDS | Chinese USA | Flash Point | 203.6±25.7 °C | |
Symbol |
GHS06 |
Signal Word | Danger |
Use of CytisineCytisine is an alkaloid that occurs naturally in several plant genera, such as Laburnum and Cytisus. Cytisine is a partial agonist of α4β2 nAChRs[1], and partial to full agonist at β4 containing receptors and α7 receptors[2]. has been used medically to help with smoking cessation[3]. |
Name | cytisine |
---|---|
Synonym | More Synonyms |
Description | Cytisine is an alkaloid that occurs naturally in several plant genera, such as Laburnum and Cytisus. Cytisine is a partial agonist of α4β2 nAChRs[1], and partial to full agonist at β4 containing receptors and α7 receptors[2]. has been used medically to help with smoking cessation[3]. |
---|---|
Related Catalog | |
Target |
α4β2 nAChRs[1]. |
In Vitro | Cytisine (2.5, 5 and 10 mM) is capable of inducing apoptosis in HepG2 cells[4]. Treatment with Cytisine increases the percentage of cells in the sub-G1 phase (P<0.01). The preincubation of HepG2 cells with Cytisine (2.5, 5 and 10 mM) significantly increases the sub-G1 cell population[4]. |
In Vivo | Cytisine (5 mg/kg, i.p.) eat less and gain less weight than those that receive the vehicle[2]. Total pellet intake increases during Cytisine substitution relative to nicotine and animals self-administered Cytisine significantly less than nicotine[2]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 413.0±34.0 °C at 760 mmHg |
Melting Point | 154-156ºC |
Molecular Formula | C11H14N2O |
Molecular Weight | 190.242 |
Flash Point | 203.6±25.7 °C |
Exact Mass | 190.110611 |
PSA | 34.03000 |
LogP | 0.07 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.623 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H315-H319-H335 |
Precautionary Statements | P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic |
Risk Phrases | R25;R36/37/38 |
Safety Phrases | S26-S28-S36/37-S45 |
RIDADR | UN 2811 |
WGK Germany | 3 |
RTECS | HA4025000 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 2933990090 |
Precursor 9 | |
---|---|
DownStream 3 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
Pharmacol. Biochem. Behav. 130 , 1-8, (2015) The role of neuronal nicotinic acetylcholine receptors (nAChR) containing the β4 subunit in tolerance development and nicotinic binding site levels following chronic nicotine treatment was investigate... |
|
Pharmacokinetics of cytisine, an α4 β2 nicotinic receptor partial agonist, in healthy smokers following a single dose.
Drug Test. Anal. , doi:10.1002/dta.1707, (2014) Cytisine, an α4 β2 nicotinic receptor partial agonist, is a plant alkaloid that is commercially extracted for use as a smoking cessation medication. Despite its long history of use, there is very litt... |
|
Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
J. Med. Chem. 49 , 2673-2676, (2006) We report the synthesis and pharmacological properties of several cytisine derivatives. Among them, two 10-substituted derivatives showed much higher selectivities for the alpha4beta2 nAChR subtype in... |
CYTISINE |
(1R,9S)-7,11-Diazatricyclo[7.3.1.0]trideca-2,4-dien-6-one |
Cytitone |
(1R)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido-[1,2-a][1,5]diazocin-8-one |
1,5-Methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R,5S)- |
1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R,5S)- |
(1R,5S)-3,4,5,6-Tetrahydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-8(2H)-one |
MFCD00136048 |
Sophorin |
Sophorin (VAN) |
Ulexin |
Cytisine (-) |
Tabex |
Tsitafat;Lupinidine |
EINECS 207-616-0 |
Baptitoxin |
(1R,5S)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one |
Tsitafat |
(-)-Cytisine |
Ulexine |
Cytiton |
Sophorine |
Cytisin |
Baptitoxine |
Laburnin |